Dermatological toxicities such as papulopustular rash (acneiform eruption), erythema, and skin fissures are common side effects of targeted cancer agents such as EGFR inhibitors [12], as EGFR is involved in the normal development and physiology of the epidermis. Here, EGFR is linked to Erythema.